ADAFLEX®(Immediate release melatonin tablet)

Clinical Indication

Sleep disorders in children (see comments). Continued in adults if proven efficacy in childhood


Doses of 10mg or less. See LLR APC melatonin guide for children for place in therapy and additional information

Date of classification

July 2022


Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .